Keynote address: Glutathione modulation in cancer treatment: Will it work?
- 31 May 1989
- journal article
- review article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 16 (5) , 1289-1295
- https://doi.org/10.1016/0360-3016(89)90301-5
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- γ‐glutamyl transpeptidase (γ‐GT) and maintenance of thiol pools in tumor cells resistant to alkylating agentsJournal of Cellular Physiology, 1987
- Enhanced melphalan cytotoxicity in human ovarian cancer in vitro and in tumor-bearing nude mice by buthionine sulfoximine depletion of glutathioneBiochemical Pharmacology, 1987
- Combined radiation-protective and radiation-sensitizing agents III: Radiosensitization by misonidazole as a function of concentrations of endogenous glutathione or exogenous thiolsInternational Journal of Radiation Oncology*Biology*Physics, 1986
- The relationship of SR-2508 sensitizer enhancement ratio to cellular glutathione levels in human tumor cell linesInternational Journal of Radiation Oncology*Biology*Physics, 1986
- The effect of L-buthionine sulfoximine on the aerobic radiation response of A549 human lung carcinoma cellsInternational Journal of Radiation Oncology*Biology*Physics, 1986
- Enhancement of misonidazole radiosensitization by buthionine sulphoximineRadiotherapy and Oncology, 1984
- Clinical trials of radiosensitizers: What should we expect?International Journal of Radiation Oncology*Biology*Physics, 1984
- Selective Modification of Glutathione MetabolismScience, 1983
- Enhancement of Misonidazole Radiosensitization by an Inhibitor of Glutathione BiosynthesisInternational Journal of Radiation Biology and Related Studies in Physics, Chemistry and Medicine, 1983
- Radiosensitization of Hypoxic Tumor Cells by Depletion of Intracellular GlutathioneScience, 1982